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arteries (D-TGA) in the current surgical era. The arterial switch operation (ASO) has replaced atrial switch procedures
for D-TGA, and 90% of patients now reach adulthood. The Adult Congenital and Pediatric Cardiology Council of the
American College of Cardiology assembled a team of experts to summarize current knowledge on genetics, pre-natal
diagnosis, surgical timing, balloon atrial septostomy, prostaglandin E1 therapy, intraoperative techniques, imaging,
coronary obstruction, arrhythmias, sudden death, neoaortic regurgitation and dilation, neurodevelopmental (ND) issues,
and lifelong care of D-TGA patients. In simple D-TGA: 1) familial recurrence risk is low; 2) children diagnosed pre-natally
have improved cognitive skills compared with those diagnosed post-natally; 3) echocardiography helps to identify risk
factors; 4) routine use of BAS and prostaglandin E1 may not be indicated in all cases; 5) early ASO improves outcomes
and reduces costs with a low mortality; 6) single or intramural coronary arteries remain risk factors; 7) post-ASO
arrhythmias and cardiac dysfunction should raise suspicion of coronary insufﬁciency; 8) coronary insufﬁciency and
arrhythmias are rare but are associated with sudden death; 9) early- and late-onset ND abnormalities are common;
10) aortic regurgitation and aortic root dilation are well tolerated; and 11) the aging ASO patient may beneﬁt from
“exercise-prescription” rather than restriction. Signiﬁcant strides have been made in understanding risk factors for
cardiac, ND, and other important clinical outcomes after ASO. (J Am Coll Cardiol 2014;64:498–511) © 2014 by the
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499TABLE 1 D-TGA Pathways and Genes
Final common pathways of TGA
Key embryo-molecular targets disrupted
Nodal signaling pathway
Neural crest
L-R patterning
TGA-causing genes
Mediator complex subunit 13-like gene (MED13L)/PROSIT240
Cryptic protein (CFC1)
Zic3
FoxH1
Growth differentiation factor-1 gene (GDF1)
Nodal
NPHP4
L-R ¼ left-right asymmetry; TGA ¼ transposition of the great arteries.
ABB R E V I A T I O N S
AND ACRONYMS
ASO = arterial switch operation
CMR = cardiac magnetic
resonance
CT = computed tomography
D-TGA = d-loop transposition
of the great arteries
LV = left ventricular
N-AR = neoaortic regurgitation
PDA = patent ductus arteriosus
PGE = prostaglandin E1
SCD = sudden cardiac death
SPECT = single-photon
emission computed
tomographyT he arterial switch operation (ASO) has nowreplaced the atrial switch procedures devel-oped byMustard (1) and Senning (2) tomanage
D-loop transposition of the great arteries (D-TGA).
Since Jatene et al. (3) performed the ﬁrst successful
ASO in 1975, survival rates have increased with
reﬁnement of surgical techniques and improved
medical management. Currently, most treated pa-
tients live to adulthood, with a 20-year survival
rate of nearly 90%.
This paper aims to update clinicians on the man-
agement of patients with D-TGA and an intact
(or virtually intact) ventricular septum who undergo
the ASO, utilizing a “timeline” approach (Central
Illustration).
GENETICS
D-TGA accounts for 5% to 7% of all congenital heart
defects (CHDs), with a prevalence of 0.2 per 1,000 live
births and male preponderance (4–6). Sibling recur-
rence rates of 0.27% and 2%, respectively, have been
noted in simple and complex forms associated with a
functional single ventricle or heterotaxy (6–8). Among
parents and siblings, the mean recurrence risk for CHD
is 1.4% (7,8). Causative mutations have been reported
in the Nodal signaling pathway (Table 1) (9,10).
Mutations in Zic3, initially known to cause X-
linked heterotaxy, have also been shown to cause
sporadic and familial D-TGA; abnormalities in other
nodal pathway genes, such as CFC1 and FoxH1, have
been associated with isolated or syndromic D-TGA
(9–11). In addition, PROSIT240 (also termed THRAP2
or MED13L) mutations have been identiﬁed in pa-
tients with D-TGA with or without intellectual
disability (12). Neural crest induction has long been
considered a major target in the development of
D-TGA and other conotruncal defects (13), supporting
the concept that genetic variants or susceptibility
alleles within 1 or more developmental pathways
may dysregulate signaling in a synergistic fashion.
Clinical genetic testing is currently not widely
available for D-TGA, with comparative genomic hy-
bridization and ﬂuorescence in situ hybridization
reserved for patients with multiple congenital
anomalies and syndromes.
PRE-OPERATIVE CARE
PRE-NATAL DIAGNOSIS. Accurate pre-natal diag-
nosis minimizes infant risk as well as improves
outcomes. Relying solely on ﬁrst and early second
trimester transvaginal fetal echocardiography is not
recommended, based on available evidence (14).Hypermobility of the atrial septum and
reverse diastolic patent ductus arteriosus
(PDA) ﬂow may predict the need for an ur-
gent balloon atrial septostomy (BAS) (15).
However, as pre-natal prediction of intera-
trial communication adequacy is imperfect, it
is recommended that neonates with D-TGA
be delivered in a center equipped to perform
BAS. Children with D-TGA diagnosed pre-
natally have better early complex cognitive
skills, particularly executive function, as
compared with those diagnosed post-natally,
in whom pre-operative acidosis and profound
hypoxemia are more common (16).
TIMING AND LOCATION OF DELIVERY. Once
fetal diagnosis is made, a multidisciplinary
team approach helps improve outcomes and
shorten the time to intervention (17). Barring obstetric
indications, delivery at 39 to 40weeks is preferred (18),
as the last 6 weeks of gestation are a critical period of
growth and development, particularly for the brain
and lungs. Disturbing the intrauterine milieu during
the latter part of gestation may impact long-term
neurodevelopmental (ND) and respiratory outcome
(19). In late gestation, the transposed fetal circulation
results in lower substrate delivery to the rapidly
developing brain, which may account for higher-than-
expected incidence of microcephaly, white matter
injury, and cortical immaturity seen on neonatal
magnetic resonance scans. Current data suggest better
ND outcomes in children delivered at term (20–23).
Available evidence supports the recommendation that
institutions that do not perform the ASO should coor-
dinate maternal transfer soon after the fetal diagnosis
is made (24).
PULSE OXIMETRY. Although added to the Uniform
Screening Panel for newborns in 2011, pulse oximetry
CENTRAL ILLUSTRATION Hot Topics in Diagnosis, Management, and Follow-Up
of Patients With D-TGA
A timeline approach to the management and surveillance of patients with d-transposition of
the great arteries (D-TGA), with emphasis on pre-operative, perioperative and life-long care.
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result in timely diagnosis of newborns with D-TGA
who may have eluded pre-natal detection.
IMAGING. Transthoracic echocardiography is used
in D-TGA to conﬁrm the pre-natal diagnosis and
obtain details of the anatomy. Malaligned commis-
sures and a single coronary ostium have been
associated with late coronary events and death after
ASO (26).
PROSTAGLANDIN THERAPY. Most hypoxemic neo-
nates with D-TGA will beneﬁt from early institution of
prostaglandin E1 (PGE) alone. However, neonates
with inadequate intracardiac mixing due to
a restrictive foramen ovale will not improve solely on
PGE. In this setting, the markedly increased pulmo-
nary blood ﬂow from the PDA may lead to deleterious
left atrial hypertension, pulmonary congestion, and
low cardiac output requiring urgent BAS.
With medical management, w90% of neonates
with D-TGA are relatively stable and undergo
electively-timed ASO; however, pre-operative man-
agement and the exact timing of surgery vary by
institution. Clinicians confront an analysis of com-
peting risks in which one must weigh the relative
risks and beneﬁts of: 1) BAS; 2) PGE and a resultant
PDA; and 3) timing of neonatal surgery.
RISKS OF BAS. BAS may be associated with vascular
trauma, atrial arrhythmias, atrial perforation andtamponade, with conﬂicting data regarding an
increased risk of stroke. Some reports link embolic
brain injury to BAS (27,28) although this has been
refuted by others (29–31).
RISKS OF PGE. PGE can cause apnea, hypotension,
and fever (especially in neonates with lower birth
weight) as well as produce a false sense of security
in the pre-operative neonate who appears to have
“adequate” oxygen saturations. While awaiting ASO,
neonates remain at risk for mechanical ventilation,
infection, medical errors, paradoxical emboli, in-
creased cost, and a longer hospital stay (32).
A reassuring peripheral oxygen saturation level
may be associated with paradoxically low cerebral
oxygen delivery. Cerebral venous oxygen saturation
is signiﬁcantly lower than predicted from the arterial
or mixed venous oxygen saturation in neonates
with a run-off lesion (33,34). Mean cerebral oxygen
saturations in children with a PDA and normal sys-
temic oxygen saturations are in the low 50% range
and are likely lower in D-TGA (33). Even a few days
delay in ASO, particularly if accompanied by signif-
icant hypoxemia, may increase central nervous
system injury, speciﬁcally to white matter (30).
Eliminating hypoxemia earlier may help improve
motor outcomes and brain growth in certain sub-
groups (35).
TIMING OF SURGERY. Conceptually, waiting several
days after birth before an ASO has potential beneﬁts:
1) transition from fetal to neonatal circulation; 2)
reduction in pulmonary vascular resistance; 3) kid-
ney and liver function improvement; 4) initiation of
enteral nutrition; 5) evaluation for other congenital
anomalies; and 6) family preparation for surgery.
However, risks relating to BAS, prolonged exposure
to PGE and PDA physiology, longer duration of
hypoxemia, lower cerebral oxygen delivery, and
paradoxical emboli, may counteract the beneﬁts of
“elective” delay.
Earlier ASO may have an ND beneﬁt (30) and may
reduce hospital morbidity, complications, and cost.
One study supports 3 days of age as the ideal time
for an ASO (24); others suggest the ASO can be safely
performed even as early as within hours of birth us-
ing autologous umbilical cord blood to prime the
bypass circuit (36,37). These recommendations
require longer follow-up and multi-institutional
validation, but insinuate that delays in performing
the ASO should be minimized. Clinicians are in-
creasingly scheduling elective ASOs within 2 to 4
days of diagnosis, although the decision to perform a
BAS, as well as when or whether to discontinue PGE
after BAS, remains institution-speciﬁc.
FIGURE 1 The Lecompte Maneuver and ASO
(A) Magnetic resonance angiogram in a patient with d-transposition of the great arteries
(D-TGA) after the arterial switch operation (ASO) with the Lecompte maneuver. Note the
position of the neo-main pulmonary artery (MPA) and branches anterior to the ascending
aorta (AAo). (B) The ASO. (a) Typical anatomy and cannulation for surgery. The sites for
implantation of the coronary arteries have been marked on the pulmonary root. (b) The
great vessels have been divided above the sinotubular junction and the coronary buttons
have been excised and mobilized. (c) The coronary buttons have been implanted into the
pulmonary root with medially-based trap-door incisions. (d) The pulmonary artery bifur-
cation has been moved anterior to the aorta. The Lecompte maneuver and the anastomosis
of the ascending aorta to the proximal neoaortic root have been initiated. (e) The defect
in the aorta created by excising the coronary buttons is being repaired with a single
“pantaloon” patch creating the neopulmonary root. (f) The pulmonary artery has been
anastomosed to the neopulmonary root.
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501Timing of the ASO proves particularly challenging
in premature and low-birth-weight neonates due to
the heightened surgical risk and morbidity of BAS
and PGE therapy in smaller infants (38,39). Although
not speciﬁcally investigated in D-TGA, among het-
erogeneous groups of CHD, the relationship of risk
to weight is nonlinear with an inﬂection point at
w2.0 to 2.2 kg (40).
ASO SURGICAL CHALLENGES
Simple in concept, the ASO remains one of the most
complex neonatal operations. The great arteries are
divided and followed by a Lecompte maneuver
(Fig. 1A). After transferring the coronary arteries, the
surgeon reconnects the great arteries to the proper
ventricle and closes any intracardiac communication
(Fig. 1B). Mortality risk factors include lesser institu-
tional and surgeon experience, smaller patient size,
side-by-side great vessel arrangement, left ventricu-
lar (LV) hypoplasia, LV outlet obstruction, and arch
abnormalities, as well as intramural and single coro-
nary artery (41–50). Early mortality is almost always
due to difﬁculty with coronary artery transfer
resulting in myocardial ischemia (41,51). Table 2
summarizes surgical series focusing on survival and
risk factors for mortality. Two recent studies
demonstrate a hospital survival rate of >98% (24,52).
Data from the United Kingdom’s National Institute
for Cardiovascular Outcomes show a nationwide
30-day mortality rate for the ASO at <3% with a
1-year survival rate of >96% (53).
Transfer of the coronary artery origins is the key to
a successful ASO. After cross-clamping and dividing
the aorta, the surgeon excises the sinus aorta, which
surrounds the coronary ostia, the so-called “coronary
button.” The button’s boundary is 1 to 2 mm of sinus
aorta surrounding the coronary ostium. If the ostium
is adjacent to a commissure, the commissure should
be taken down to ensure that the button is large
enough for coronary transfer. After button excision,
the proximal coronary is mobilized to allow the
vessel to be implanted into the pulmonary root. None
of the several techniques for coronary artery im-
plantation has shown a clear advantage over the
others (54). Assessment of coronary anatomy and
adequate ﬁlling after transfer is essential. Depressed
ventricular function or inability to be weaned from
cardiopulmonary support may be considered to be
due to coronary insufﬁciency until proven otherwise.
ELECTIVE DELAYED STERNAL CLOSURE. In 2 large
series of the ASO, one-quarter to one-third of patients
had delayed sternal closure, which was associated
with worse outcomes (43,45). In a retrospective
TABLE 2 Outcome and Predictors of Early Mortality of the ASO for TGA With IVS: Publications During the Last Decade
First Author
(Ref. #), Year
Inclusive
Years N % IVS
Early
Survival for
TGA IVS, %
5-Year
Survival, %
10-Year
Survival, % Coronary Anatomic Risk Factors Other Predictors of Early Mortality
Sarris (43), 2006* 1998–2000 613 70 97 NA NA Single coronary (univariate analysis only) Open sternum
Lalezari (51), 2011 1977–2007 332 60.8 88.6 85.8† 85.2† Not a risk factor for early mortality Technical problems with
coronary transfer
Fricke (85), 2012 1983–2009 618 64 98.2 98 97 Not a risk factor for early mortality Weight <2.5 kg ECMO
Khairy (41), 2013 1983–1999 400 59.5 93.5† NA 92.7† Single right coronary artery Post-operative heart failure
Cain (52), 2014 2000–2011 70 100 98.6 NA NA None identiﬁed No predictors of early mortality,
but earlier repair <4 days of age
was associated with decreased
resource utilization
Anderson (24), 2014 2003–2012 140 75 98.6 NA NA None identiﬁed No predictors of early mortality,
but earlier repair <4 days of age
was associated with decreased
resource utilization
*Multicenter study of early results only from the European Congenital Heart Surgeons Association. †Results include outcomes of all patients undergoing the ASO and are not conﬁned to those with intact
ventricular septum.
ASO ¼ arterial switch operation; ECMO ¼ extracorporeal membrane oxygenation; IVS ¼ intact ventricular septum; TGA ¼ transposition of the great arteries with intact septum.
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502study, elective delayed sternal closure afforded no
beneﬁt (55). Although delayed sternal closure is used
commonly and may be necessary in patients who
have had a prolonged and complicated operation,
routine delayed sternal closure cannot be recom-
mended based on the available evidence.
HEMODYNAMIC AND NEUROLOGICAL MONITORING.
Following an uncomplicated ASO, the post-operative
course is typically uneventful, with the opportunity
to rapidly “de-intensify” the patient. Standard
monitoring includes electrocardiogram (ECG), inva-
sive arterial and central venous pressure, pulse ox-
imetry, and capnography. Formerly standard (56),
transthoracic left atrial lines are used primarily when
concerns of potential LV dysfunction arise. Venous
saturation monitoring or pulmonary artery catheters
may be considered in select cases (56–58).
Near infrared spectroscopy is considered both a
hemodynamic and neurological monitor, with in-
creasing reports of the predictive validity of low
cerebral near infrared spectroscopy values and
later ND disabilities (58–60). Some centers advocate
continuous electroencephalography, transcranial
Doppler, strict glycemic control, and measurement
of biomarkers such as S100b to identify infants at
risk for ND abnormalities. These newer techniques
cannot currently be recommended as standard ther-
apy, as the results have been disparate (61–63). A
recent systematic review suggested that the only
strategy that could be “recommended” was avoiding
extreme hemodilution during the ASO (64).
TIMING OF EXTUBATION. In the past, post-operative
care following the ASO frequently included deepsedation and neuromuscular blockade (57). However,
evidence increasingly associates prolonged mechani-
cal ventilation with increased risk of pneumonia,
longer hospital length of stay, and increased cost (65).
In the absence of signiﬁcant hemodynamic instability
or bleeding, 1 recent meta-analysis of a heterogeneous
patient group suggests that early extubation (<6 h
after surgery) can be achieved safely with amore rapid
pace of recovery and fewer complications (66).
EARLY POST-OPERATIVE EVALUATION. In most
infants with early post-operative ischemia, global
and/or regional ventricular dysfunction is seen by
echocardiography (49,67). Unexplained profound
ventricular dysfunction, low cardiac output syn-
drome, or hemodynamically signiﬁcant arrhythmias,
including supraventricular tachycardia, junctional
ectopic tachycardia, or ventricular tachycardia,
should raise suspicion of early coronary insufﬁciency
(41,46,51,68,69). Cardiac catheterization and angiog-
raphy is the preferred method to evaluate coronary
obstruction in the unstable neonate. Computed to-
mography (CT) post-ASO is limited by rapid neonatal
heart rate and high radiation doses. Cardiac magnetic
resonance (CMR) is limited by tachycardia and low
spatial resolution.
THE “LATE” ASO
Although ideal, neonatal ASO demands early diag-
nosis and rapid access to a surgical center (24). When
these are unavailable—as in much of the world—one
must choose between a late ASO, with or without
some form of preparation of the left ventricle, or an
80
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FIGURE 2 Technical Performance Score
Post-operative hospital length of stay (PHLOS), ventilation time, and complications across
Technical Performance Score (TPS) classes in a 2011 multicenter cohort that includes both
arterial switch operation (ASO) and ASO/VSD. The x-axis represents days for length of stay
and ventilation time and % for complications. Class 3 patients fared worse when compared
with class 1 after adjusting for age, prematurity, and presence of chromosomal anomalies,
as well as center and cardiopulmonary bypass times. Class 1 ¼ no residual; class 2 ¼ minor
residual defects; and class 3 ¼ major residual defects or unplanned reintervention in
anatomic area of repair. Vent ¼ post-operative duration on ventilator; VSD= ventricular
septal defect.
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503atrial switch. In the 1980s and early 1990s, prepara-
tion of the left ventricle by banding the pulmonary
artery was used as an alternative to a Senning or
Mustard procedure, albeit with signiﬁcant risk. Pri-
mary ASO may be used in patients >2 months of age
with only a slight increase in early morbidity and
mortality, with 5.7% requiring post-operative me-
chanical assistance in 1 study (70). Other studies
show comparable outcomes of the late ASO in chil-
dren up to 8 years of age, with only a mild increase in
morbidity and resource consumption (71–74). Those
undergoing the 2-stage ASO fared the worst. Long-
term data are limited, and there is a need for a
multicenter study to deﬁne risk factors and the abil-
ity of the left ventricle to meet expected demands
(75). A recent study from China reports that children
with D-TGA >6 months of age at the time of ASO had
quality-of-life scores indistinguishable from their
normal peers (76).
TECHNICAL PERFORMANCE SCORE
The ASO remains a technically challenging operation
with many components that require perfection for
optimal outcomes. The technical performance score
(TPS) assesses the adequacy of a repair as class 1
(optimal, no residua), class 2 (adequate, minor
residua), or class 3 (inadequate, major residua, or
unplanned reintervention or placement of a perma-
nent pacemaker prior to discharge) based on speciﬁc
echocardiographic and clinical criteria (77). TPS cor-
relates with pre-discharge outcomes such as duration
of ventilatory support, post-operative length of stay,
and complications (Fig. 2), as well as post-discharge
outcomes, such as unplanned reinterventions (Fig. 3).
Thus, TPS may help identify which patients are likely
to require increased surveillance.
PEDIATRIC CARDIAC CARE CONSORTIUM. The Pe-
diatric Cardiac Care Consortium, a registry founded
to support quality improvement in cardiac surgery,
has collected event outcome data from 45 small to
midsize centers in North America. The registry has
a total of 1,835 patients with D-TGA who underwent
ASO between 1982 and 2007. Since 1984, more than
1,700 neonatal ASOs have been reported with a mean
patient age of 7 days at repair and in-hospital and
30-day overall mortality rates of 7.8% and 6.6%,
respectively. The number of neonatal procedures and
mortality by year is presented in Figure 4. The post-
operative mortality rate has dropped to 2.9% in the
last 5 years. The overall mortality rate in children
with a late ASO (median age 49 days, range 29 to 232
days, n ¼ 43) was 5.4%.QUALITY METRICS
To address the lack of consensus regarding appro-
priate follow-up for D-TGA after ASO, the American
College of Cardiology Adult Congenital and Pediatric
Cardiology Council used the RAND methodology (78)
to develop quality measures for ambulatory care.
Quality measures include: 1) post-operative echocar-
diography between 3 and 12 months of age; 2) neu-
rodevelopmental assessment; 3) screening lipid
proﬁle by 11 years of age; and 4) documentation
of a transition plan to adult providers at 18 years
of age.
Post-operative management for D-TGA after ASO
was the ﬁrst condition to be included in an innova-
tive learning system known as Standardized Clinical
Assessment and Management Plans (SCAMPs) to
optimize care delivery (79). Initial analyses using
TGA/ASO SCAMP algorithms reduced projected clinic
visits and echocardiograms compared with control
subjects (80). Subsequent iterations resulted in cost
reductions by eliminating testing that had low clin-
ical beneﬁt and limiting expensive tests such as CMR
to high-risk patients.
100%
80%
60%
40%
20%
0%
0 500 1,000 1,500 2,000
Follow-Up in Days
ASO
Fr
ee
do
m
 fr
om
 R
e-
In
te
rv
en
tio
n
p<0.001
Technical
Performance Score
Optimal
Adequate
Inadequate
Optimal-censored
Adequate-censored
Inadequate-censored
FIGURE 3 Reintervention After the ASO
Kaplan-Meier estimate of freedom from reintervention in a cohort of 70 subjects following
arterial switch operation (ASO) for d-transposition of great arteries with intact ventricular
septum (D-TGA/IVS) followed over 4 years. Class 3 patients (red line) had signiﬁcantly
higher reinterventions when compared with class 1 (blue line) patients. Green line
indicates class 2 patients. The small hatch marks in each of the lines represents the
duration of follow-up for each patient. Classes as deﬁned in Figure 2.
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504LIFELONG FOLLOW-UP CARE
After the ASO, patients may have residual lesions
and/or sequelae from interventions that require life-
long surveillance and care. Effective transition of
care from a pediatric to an adult congenital specialist
is essential (81,82). Recommended practices to help
facilitate this transition have been published (83) but
are not yet universally employed (84).
Survival into adulthood after ASO is common, and
reoperation risk is low (85). However, ASO includes
lifelong consequences, some of which may still be
unrecognized, requiring ongoing medical surveil-
lance. To date, neopulmonary stenosis, neoaortic
regurgitation, neoaortic root dilation, and coronary
artery disease have been noted. Chronotropic in-
competence, exercise intolerance, and sudden car-
diac death (SCD) constitute additional concerns.
Lifelong management of the ASO population poses
several challenges: 1) the absence of current con-
sensus regarding the appropriate interval and mo-
dality for surveillance imaging; 2) lack of deﬁned
management strategy when subclinical anatomic or
physiologic abnormalities are identiﬁed; 3) the rarity
of symptoms attributable to potential complica-
tions, especially coronary obstruction, and therefore,practitioners must be vigilant for classic and atypical
presentations; and 4) the unknown effects of ac-
quired coronary artery disease superimposed on
manipulated coronary arteries. To date, almost 40
years after the initial ASO, we have identiﬁed a
number of long-term consequences (Table 3).
MYOCARDIAL ISCHEMIA. Obstructed coronary ar-
teries are present in 5% to 7% of survivors (41,86–89)
and remain the most common cause of morbidity and
mortality following ASO. The incidence of myocardial
ischemia, infarction, and death is most prevalent in
the ﬁrst 3 months after ASO. When ostial stenosis is
identiﬁed in childhood, annual ECGs and echocardi-
ography are recommended with advanced imaging if
indicated.
Coronary obstruction late after the ASO is uncom-
mon and is more frequently anatomic than physio-
logic. In 1 long-term study, freedom from coronary
events was 88.1  6.4% at 22 years (80). Selective
coronary angiography has been considered the gold
standard for anatomic evaluation of the coronary
lumen (90); intimal thickening may be detected by
intravascular ultrasound (91). Although associated
with radiation exposure, modern ECG-gated CT angio-
graphy provides excellent spatial resolution to eval-
uate the coronary arteries and is considered by many
the study of choice for morphologic assessment in
young adults with ASO (92,93). CMR angiography
offers lower spatial resolution but can provide
additional functional information (e.g., myocardial
viability, aortic regurgitation) (94). Detection of sub-
clinical myocardial ischemia after the ASO remains a
challenge. Clinical evaluation, ECG, and echocardi-
ography possess low sensitivity for detecting coronary
insufﬁciency (87).
Exercise testing is the preferred modality for
physiologic assessment, but pharmacologic stress
with dobutamine or a coronary vasodilator (e.g.,
adenosine) may also be used. Stress echocardiography
and CMR can detect regional wall motion abnormal-
ities. Single-photon emission computed tomography
(SPECT), positron emission tomography, or ﬁrst-
pass perfusion CMR may detect perfusion defects.
Exercise-induced myocardial perfusion defects are
present by SPECT in 5% to 10% of patients, whereas
symptoms and ST-segment depression are rare and
of unclear signiﬁcance (95–97). SPECT should be re-
served for high-risk patients, including those with
exercise-induced symptoms suggestive of ischemia,
atypical coronary variants, or intramural coronaries;
those who had coronary button re-implantation; or
those in whom electrocardiographic markers of
ischemia are unreliable.
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FIGURE 4 Neonatal ASO for D-TGA by Year in the PCCC Registry (1984 to 2007)
Graph of neonatal ASOs for D-TGA and post-operative mortality registered in the Pediatric Cardiac Care Consortium (PCCC) between 1984
and 2007 by year of surgery. Abbreviations as in Figure 1.
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505NEOAORTIC ROOT DILATION AND AORTIC
REGURGITATION. Neoaortic valve regurgitation (N-
AR) is a long-term consequence of the ASO. Freedom
from N-AR of grades IV, III, and II at 23 years was 90.2
 6.6%, 70.9  9.6%, and 20.3  5.5%, respectively.
Older age at time of ASO, presence of ventricular
septal defect, bicuspid pulmonic valve, previous
pulmonary artery banding, perioperative mild N-AR,
and higher neoaortic root/ascending aorta ratio are
risk factors for N-AR (98–100). Neoaortic root dilation
also occurs as a consequence of ASO (101,102),TABLE 3 Post-Operative Sequelae Following the
Arterial Switch Operation
Long-Term Post-Operative Sequelae Incidence
Supravalvular pulmonary stenosis* w10%
Supravalvular aortic stenosis* w5%
Neoaortic root dilation Nearly universal
Neoaortic regurgitation Most (moderate or
severe in <10%)
Asymptomatic coronary occlusion 2%–7%
Sudden cardiac death <1%
Arrhythmia 2%–10%
Aortic dissection or rupture Unknown
*Requiring intervention. Modiﬁed with permission from Wernovsky et al. (152).especially with a size discrepancy of the great arteries
(103). Fortunately, aortic root dilation has not pro-
gressed signiﬁcantly during the current duration of
follow-up nor has it been associated with acute aortic
dissection or increased mortality (104).
REOPERATION LATE AFTER ASO
A single-center study reporting the outcomes of
400 subjects revealed that although 75% of patients
with good functional status were free from inter-
vention at 25 years of follow-up, between 3% and
10% developed moderate neoaortic or neopulmonary
regurgitation and stenosis (63). Anywhere from 2% to
8% of patients may require intervention, including
balloon angioplasty, transcatheter stenting, or surgi-
cal patch arterioplasty (99,105,106). The ASO re-
operation study revealed that pulmonary artery
reconstruction was required earlier than neoaortic
intervention (5.4  6.8 years vs. 13.8  7.7 years,
p < 0.001) (107). Freedom from pulmonary stenosis
(PS) of $36 and $20 mm Hg at 23 years was 34 
18.0% and 17.7  9.6%, respectively, but the inci-
dence may be steadily declining (106). Coronary
grafting is indicated in a very small group of patients
(86,99,108).
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CHRONOTROPIC IMPAIRMENT
Normal sinus node function is present in 96% to
99% of patients after the ASO (41). Chronotropic
impairment due to abnormal autonomic function
from sympathetic denervation can be found consis-
tently post-ASO (41,50,69,109). Late arrhythmia oc-
curs in 2.4% to 9.6% of patients (41,50,69,110,111).
Most late post-operative arrhythmias occurring
beyond 30 days are associated with residual hemo-
dynamic lesions or coronary artery abnormalities,
particularly occlusion. Late post-operative supra-
ventricular tachycardia, especially atrial ﬂutter or
ﬁbrillation, is associated with right ventricular
outﬂow tract obstruction and/or signiﬁcant tricuspid
regurgitation (49,69,110). Late ventricular tachycar-
dia may be scar-related or secondary to ischemia and
is typically amenable to ablation therapy (111,112).
SUDDEN CARDIAC DEATH. Most deaths occur 1 to 5
years after the ASO, although some happen later,
possibly related to exercise-induced external com-
pression of unusually distributed coronary arteries
(41). Studies have reported a 0.3% to 0.8% incidence
of sudden cardiac death (SCD), which is thought to be
related to primary arrhythmia, myocardial ischemia,
or infarction (41,50,85,110,111,113). Although early
SCD is often linked to technical difﬁculties during
coronary transfer (87), ventricular ﬁbrillation and
late SCD are usually associated with myocardial
ischemia or infarction from coronary obstruction or
intimal proliferation. Whether these are related to
atypical or intramural coronary arteries remains un-
clear (51,69,85,114,115). High-risk patients with a his-
tory of atypical, intramural, or problematic coronary
re-implantation may require in-depth screening prior
to engaging in high-level physical activity (96,116).
ANTICIPATORY CARE: LIFESTYLE CHOICES,
CHOLESTEROL, HYPERTENSION,
AND EXERCISE
Neonatal coronary manipulation, potential endothe-
lial stress, and ongoing aortic root pathology make
coronary risk factor management—particularly
obesity, dyslipidemia, hypertension, inactivity, and
smoking—integral to lifelong care (117,118). In adults
with structurally normal hearts, data suggest that
statins may be used electively in at-risk individuals,
regardless of low-density lipoprotein levels. This
recommendation needs further investigation in ASO
patients. According to a recent study, obese teen-
agers with ASO typically exhibit higher blood pres-
sure, higher LV mass index, lower brachial arteryreactivity (suggestive of endothelial abnormality),
higher triglyceride with lower high-density lipopro-
tein levels, and increased carotid intimal-medial
thickness compared with normal-weight individuals
(118). Unfortunately, the incidence of obesity after
the ASO soars (119), making this a potential signiﬁ-
cant future morbidity. These individuals have limited
aerobic capacity on exercise testing (120). Addition-
ally, atypical coronary anatomy, pulmonary artery
stenosis, and ventilatory inefﬁciency are associated
with decreased aerobic capacity (118,121,122).
LV function may be preserved despite decreased
aerobic capacity, which implicates the aforemen-
tioned noncardiac etiologies, including physical
deconditioning and obesity. In the presence of
normal LV function, the aging ASO population may
beneﬁt from increased physical activity and condi-
tioning (e.g., an exercise “prescription” rather than
“restriction”). European recommendations support
active lifestyles, including recreational and competi-
tive sports for most (123).
CENTRAL NERVOUS SYSTEM
AND ND OUTCOMES
Much of what we know about ND outcomes in
congenital heart disease has been learned from chil-
dren with D-TGA (124–128). Given the high frequency
of ND abnormalities in this population (18,129,130),
all D-TGA patients should have an ND evaluation,
ideally in early childhood, in keeping with the recent
recommendations of the scientiﬁc statement from
the American Heart Association and American Acad-
emy of Pediatrics (131). Emerging evidence shows
that therapies directed toward improving maternal
well-being as well as early therapies for the infant
may improve long-term outcomes (132–134).
Most reports document a correlation between peri-
operative events—such as signiﬁcant hypoxemia,
acidosis, prolonged cardiopulmonary bypass, and
low cardiac output—and adverse ND and behavioral
testing; some events are modiﬁable or preventable
(135–137). The landmark prospective Boston Circula-
tory Arrest Study reported follow-up in D-TGA survi-
vors at 1, 4, 8 and 16 years of age (18,138–142).
Throughout follow-up, the group as a whole under-
performed in many aspects of their ND evaluations.
Researchers detected behavior, speech, and language
delays at 4 and 8 years, with signiﬁcant deﬁcits in
visual-spatial and -memory skills, as well as in com-
ponents of executive functioning such as working
memory, hypothesis generation, sustained attention,
and higher-order language skills. Although the co-
hort’s intelligence quotients were close to normal,
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507additional concerns became apparent: executive
dysfunction and “theory of mind” abnormalities were
prevalent, patients were 4 times more likely to be
taking psychotropic medications compared with car-
diovascular medications, and 65% were receiving
behavioral therapies and/or additional help at school.
One-third of patients had brain abnormalities detected
on CMR. These abnormalities have been conﬁrmed in
multiple centers worldwide (143–145).
Academic and behavioral challenges may translate
to occupational challenges in adulthood where
studies are still lacking. Despite these challenges,
quality of life has been good thus far in adolescents
(146,147).
PREGNANCY
The speciﬁc risks for the ASO population depend
on the existence and type of long-term complica-
tions. Fortunately, N-AR, the most common conse-
quence of the ASO, is well-tolerated in pregnancy.
Signiﬁcant aortic root dilation or coronary obstruc-
tion requires a multidisciplinary pre-conception
evaluation. Established risk factors include impaired
LV systolic function, ventricular tachycardia, and
mechanical systemic aortic valve thrombosis (148).
Research involving registries are underway to better
understand pregnancy risks and outcomes post-
ASO (149).
VERTICAL TRANSMISSION OF D-TGA. Genetic
counseling to elucidate vertical transmission in
D-TGA patients should take place prior to pregnancy.
Diglio et al. (6) identiﬁed 2 families in which a mother
with congenital heart disease had $1 child with
D-TGA. Interestingly, of the 370 families with D-TGA
offspring, none of the parents had D-TGA. Fesslova
et al. (150) also demonstrated a very low vertical
transmission rate. Furthermore, disease discordance
was typical, as none of the offspring of D-TGA parents
had the same disease.
INSURABILITY/EMPLOYABILITY
For many adults with CHD, physical and psychologi-
cal factors may affect both insurability and employ-
ability. Cognitive intervention in early childhood may
result in improved employment status in adulthood
(151). Patients with ASO who emerge from early
adulthood with reasonable cognitive function enjoy
positive trajectories (151).
In addition to the Americans with Disabilities Act
of 1990, the Affordable Care Act has further sup-
ported the care of adults with congenital heart dis-
ease in the United States by guaranteeing faircoverage for pre-existing conditions, increasing the
age young adults can stay on their parents’ plan,
and eliminating lifetime dollar caps on covered
services.
SUMMARY
The long-term outcomes of patients with D-TGA have
improved dramatically in the current ASO era, with
advances in pre-natal diagnosis, BAS, PGE, surgical
technique, and post-operative management.
Key points to remember:
1. Familial recurrence risk is low.
2. Children diagnosed pre-natally have improved
cognitive skills when compared with those
diagnosed post-natally. Delivery at term is
advantageous.
3. Echocardiography helps to identify risk factors
such as commissural misalignment, restrictive
patent foramen ovale, coronary abnormalities,
and acute LV dysfunction before and after ASO.
4. BAS and PGE carry risks that must be considered
in conjunction with the timing of ASO. Early ASO
may minimize these risks.
5. Early ASO improves outcomes and reduces costs.
Mortality is low despite atypical coronary anat-
omy, but single or intramural coronary arteries
remain risk factors. Based on available evidence,
routine elective delayed sternal closure is not
recommended.
6. Early post-ASO arrhythmias and cardiac dysfunc-
tion should raise suspicion of coronary insufﬁ-
ciency or obstructive lesions.
7. Though rare, arrhythmias and coronary obstruc-
tion are associated with SCD.
8. Early- and late-onset ND abnormalities occur
commonly. Perioperative events such as pre-term
delivery, BAS, prolonged PGE therapy, hypox-
emia, paradoxical embolism, acidosis, prolonged
hospital length of stay, and others are risk factors,
some of which may be modiﬁable.
9. Although common, N-AR and aortic root dilation
are well-tolerated during pregnancy and, to our
knowledge, are not associated with dissection.
10. The aging ASO patient should beneﬁt from
“exercise-prescription” rather than restriction.
CONCLUSIONS AND FUTURE DIRECTIONS
In the current era, a very low mortality rate has
replaced the previously grim natural course of the
neonate with D-TGA. Most treated patients live to
adulthood, with a 20-year survival rate of almost
90%. Although a great success story, a number of
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508uncertainties persist about ASOs. Comorbidities such
as ND abnormalities, low aerobic capacity, obesity, and
coronary disease remain challenging. Transfer of the
coronary arteries in the neonate may result in
ischemia. Longer follow-up data are needed to un-
derstand the severity and frequency of latemyocardial
ischemia, the need for reintervention, and whether
lifestyle and dietary modiﬁcations in childhood may
reduce late-onset risks. Increasing the duration of
follow-up may unmask a higher prevalence of neo-
aortic dilation and N-AR. The lifelong, as opposed to
“long-term,” consequences of this landmark surgicalprocedure remain speculative and will require the
tincture of time to test our current management.
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